Research Article
Volume 13 Issue 11 - 2021
How Successful we are in the Management of Idiopathic Intracranial Hypertension?
Buse Rahime Hasırcı Bayır1*, Can Ulutaş2, Gizem Gürsoy3, Merve Beyza Çetin4, Kemal Tutkavul5, Hülya Tireli6 and Cemile Handan Mısırlı5
11Neurology Specialist, Department of Neurology, Haydarpaşa Numune Research and Training Hospital, Istanbul, Turkey
2Neurology Residency, Department of Neurology, Haydarpaşa Numune Research and Training Hospital, Istanbul, Turkey
3Neurology Specialist, Department of Neurology, Haseki Research and Training Hospital, Istanbul, Turkey
4Ophthalmology Specialist, Department of Ophthalmology, Haydarpaşa Numune Research and Training Hospital, Istanbul, Turkey
5Professor Doctor, Department of Neurology, Haydarpaşa Numune Research and Training Hospital, Istanbul, Turkey
6Associated Professor Doctor, Department of Neurology, Haydarpaşa Numune Research and Training Hospital, Istanbul, Turkey
*Corresponding Author: Buse Rahime Hasırcı Bayır, Neurology Specialist, Department of Neurology, Haydarpaşa Numune Research and Training Hospital, Istanbul, Turkey.
Received: August 24, 2021; Published: October 29, 2021


Aim: Idiopathic intracranial hypertension is presented by headache and visual impairment and frequently seen in women of reproductive age. The present study aimed to evaluate the recovery rates of idiopathic intracranial hypertension symptoms and patient compliance with weight control and treatment during the follow-up period.

Materials and Methods: The files of 106 patients who were diagnosed as having idiopathic intracranial hypertension were examined. Idiopathic intracranial hypertension symptoms, body mass index, fundus examinations, cerebrospinal fluid opening pressure, and cranial imaging findings were obtained from their files.

Patients who accepted a phone call were questioned about their current symptoms, body mass index, and treatment of idiopathic intracranial hypertension.

Results: Forty-one patients (37 females and four males) with a mean age of 35 years were included in the study. The mean time between the patients’ symptom onset and hospitalization was 11.5 months (range, 3 days - 10 years). The mean follow-up period of the patients was 3.25 (range, 1 - 10) years and headache in 15 (36.5%) patients and visual symptoms in seven (17%) patients continued. It was observed that the average body mass index of the patients showed a minimal decrease from 32.6 kg/m2 to 31.2 kg/m2. Ten patients continued the drug treatment and 31 patients stopped the treatment within an average of 2.5 years. Eighteen patients left the follow-up voluntarily.

Conclusion: Idiopathic intracranial hypertension requires regular follow-up due to the risk of recurrence, and it was observed that our patients’ compliance with treatment and outpatient follow-up was low. However, despite this, only three patients developed permanent vision loss. This indicates that the prognosis of IIH may be better than expected, even in patients with low treatment compliance in the long term.

Keywords: Idiopathic Intracranial Hypertension; Headache; Obesity; Treatment


  1. Wall M. “Update on Idiopathic Intracranial Hypertension”. Neurologic Clinics 35 (2017): 45-57.
  2. Sundholm A., et al. “Infectious and inflammatory disorders might increase the risk of developing idiopathic intracranial hypertension - a national case-control study”. Cephalalgia 40 (2020): 1084-1094.
  3. Bruce BB., et al. “Idiopathic intracranial hypertension in men”. Neurology 72 (2009): 304-309.
  4. Andrews LE., et al. “Idiopathic intracranial hypertension and obesity”. Hormone Research Paediatrics 81 (2014): 217-225.
  5. Subramaniam S and Fletcher WA. “Obesity and Weight Loss in Idiopathic Intracranial Hypertension”. Journal of Neuro-Ophthalmology 37 (2017): 197-205.
  6. Friedman DI., et al. “Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children”. Neurology 81 (2013): 1159-1165.
  7. Wall M., et al. “The idiopathic intracranial hypertension treatment trial clinical profile at baseline”. JAMA Neurology 71 (2014): 693-701.
  8. Yri HM., et al. “The course of headache in idiopathic intracranial hypertension: A 12-month prospective follow-up study”. European Journal of Neurology 21 (2014): 1458-1464.
  9. Toscano S., et al. “An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management”. Journal of Neurology (2020).
  10. Rigi M., et al. “Papilledema: Epidemiology, etiology, and clinical management”. Eye Brain 7 (2015): 47-57.
  11. Wall M., et al. “Threshold static automated perimetry of the full visual field in idiopathic intracranial hypertension”. Investigative Ophthalmology Visual Science 60 (2019): 1898-1905.
  12. Daniels AB., et al. “Profiles of Obesity, Weight Gain, and Quality of Life in Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)”. American Journal of Ophthalmology 143 (2007): 635-641.
  13. Szewka AJ., et al. “Idiopathic intracranial hypertension: Relation between obesity and visual outcomes”. Journal of Neuro-Ophthalmology 33 (2013): 4-8.
  14. Appel LJ., et al. “Comparative effectiveness of weight-loss interventions in clinical practice”. The New England Journal of Medicine 365 (2011): 1959-1968.
  15. Ball AK and Clarke CE. “Idiopathic intracranial hypertension”. The Lancet Neurology 5 (2006): 433-442.
  16. Mallery RM., et al. “Utility of magnetic resonance imaging features for improving the diagnosis of idiopathic intracranial hypertension without papilledema”. Journal of Neuro-Ophthalmology 39 (2019): 299-307.
  17. Agid R., et al. “Idiopathic intracranial hypertension: The validity of cross-sectional neuroimaging signs”. Neuroradiology 48 (2006): 521-527.
  18. Bono F., et al. “The upper limit of normal CSF opening pressure is related to bilateral transverse sinus stenosis in headache sufferers”. Cephalalgia 30 (2010): 145-151.
Citation: Buse Rahime Hasırcı Bayır., et al. “How Successful we are in the Management of Idiopathic Intracranial Hypertension?”. EC Neurology 13.11 (2021): 50-57.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

January Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 15, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.